Benitec Biopharma Inc. (BNTC)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Jun 30
Key ratios (FY2025)
-39.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $75.0K | $73.0K | $59.0K | $97.0K | $11.55M | — |
| Operating Income | -$41.77M | -$22.49M | -$19.08M | -$17.85M | -$13.60M | -$8.28M | $2.58M | — |
| Net Income | -$37.92M | -$21.75M | -$19.56M | -$18.21M | -$13.88M | -$8.27M | $2.61M | — |
| EPS (Diluted) | $-1.05 | $-1.22 | $-14.12 | $-37.88 | $-3.23 | — | — | — |
| Total Assets | $99.59M | $52.21M | $4.46M | $5.97M | $21.38M | $11.59M | $19.23M | — |
| Total Liabilities | $2.30M | $4.96M | $4.26M | $3.09M | $1.37M | $1.35M | $2.64M | — |
| Shareholders' Equity | $97.30M | $47.25M | $202.0K | $2.88M | $20.01M | $10.24M | $16.59M | $13.84M |
| Cash & Equivalents | $97.74M | $50.87M | $2.48M | $4.06M | $19.77M | $9.80M | $15.72M | $11.88M |
| Operating Cash Flow | -$23.59M | -$19.40M | -$18.01M | -$15.90M | -$12.83M | -$7.54M | $4.79M | — |
| Capital Expenditures | $18.0K | $179.0K | $1.0K | $13.0K | $221.0K | $95.0K | $404.0K | — |
| Shares Outstanding | 26.25M | 23.45M | 1.67M | 480.7K | 8.17M | 1.11M | 856.8K | — |